JP2012502037A5 - - Google Patents

Download PDF

Info

Publication number
JP2012502037A5
JP2012502037A5 JP2011526134A JP2011526134A JP2012502037A5 JP 2012502037 A5 JP2012502037 A5 JP 2012502037A5 JP 2011526134 A JP2011526134 A JP 2011526134A JP 2011526134 A JP2011526134 A JP 2011526134A JP 2012502037 A5 JP2012502037 A5 JP 2012502037A5
Authority
JP
Japan
Prior art keywords
compound
formulation
unsubstituted
alkyl
cor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011526134A
Other languages
English (en)
Other versions
JP2012502037A6 (ja
JP2012502037A (ja
Filing date
Publication date
Priority claimed from PCT/US2009/055611 external-priority patent/WO2010027975A1/en
Application filed filed Critical
Publication of JP2012502037A publication Critical patent/JP2012502037A/ja
Publication of JP2012502037A6 publication Critical patent/JP2012502037A6/ja
Publication of JP2012502037A5 publication Critical patent/JP2012502037A5/ja
Pending legal-status Critical Current

Links

Claims (12)

  1. Figure 2012502037
    の構造を有する化合物であって、
    式中、
    は、非置換のアルキルであり、
    は、H、非置換のC−Cアルキル、COR10、および−C(O)OR10からなる群から選択され、
    式中、R10は、Hまたは非置換のC−Cアルキルである、化合物、またはその塩。
  2. Figure 2012502037
    の構造を有する、請求項1に記載の化合物。
  3. Figure 2012502037
    の構造を有する、請求項2に記載の化合物。
  4. Figure 2012502037
    の構造を有する、請求項1に記載の化合物。
  5. Figure 2012502037
    の構造を有する、請求項4に記載の化合物。
  6. Figure 2012502037
    の構造を有する、請求項4に記載の化合物。
  7. Figure 2012502037
    の構造を有する、請求項1に記載の化合物。
  8. Figure 2012502037
    の構造を有する、請求項1に記載の化合物。
  9. Figure 2012502037
    の構造を有する、請求項1に記載の化合物。
  10. (a)請求項1〜のいずれか一項に記載の化合物と、
    (b)医薬的に許容される賦形剤と、を含む、医薬製剤。
  11. 前記製剤は、単位剤形である、請求項10に記載の製剤。
  12. 前記製剤は、経口または局所使用用である、請求項10に記載の製剤。
JP2011526134A 2008-09-04 2009-09-10 ホウ素含有小分子 Pending JP2012502037A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9440508P 2008-09-04 2008-09-04
US61/094,405 2008-09-04
PCT/US2009/055611 WO2010027975A1 (en) 2008-09-04 2009-09-01 Boron-containing small molecules

Publications (3)

Publication Number Publication Date
JP2012502037A JP2012502037A (ja) 2012-01-26
JP2012502037A6 JP2012502037A6 (ja) 2012-06-07
JP2012502037A5 true JP2012502037A5 (ja) 2012-10-18

Family

ID=41797448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011526134A Pending JP2012502037A (ja) 2008-09-04 2009-09-10 ホウ素含有小分子

Country Status (4)

Country Link
US (2) US8470803B2 (ja)
EP (1) EP2348863A4 (ja)
JP (1) JP2012502037A (ja)
WO (1) WO2010027975A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1976536A4 (en) 2005-12-30 2011-03-02 Anacor Pharmaceuticals Inc SMALL MOLECULES CONTAINING BORON
DK1988779T5 (en) 2006-02-16 2016-10-10 Anacor Pharmaceuticals Inc SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS
WO2010045503A1 (en) * 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
WO2011055165A1 (en) * 2009-11-03 2011-05-12 Chemyunion Química Ltda Composition comprising a phosphate, a phosphonate, a phosphite or a phosphoramidate with polyol substructures
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
CN107375296A (zh) 2010-11-08 2017-11-24 奥默罗斯公司 使用pde7抑制剂治疗成瘾和冲动控制障碍
EA032841B1 (ru) 2011-08-19 2019-07-31 Глаксо Груп Лимитед Соединения для получения бензофуранового соединения для лечения инфекций, вызываемых вирусом гепатита с
AR088668A1 (es) * 2011-11-21 2014-06-25 Lilly Co Eli Moleculas pequeñas que contienen boro
SG11201502050XA (en) 2012-10-25 2015-04-29 Tetra Discovery Partners Llc Heteroaryl inhibitors of pde4
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
JP5927686B1 (ja) 2013-01-30 2016-06-01 アグロフレッシュ インコーポレイテッド 食肉、植物または植物の一部分に対する揮発性抗菌剤としてのベンゾオキサボロールの使用
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9598443B2 (en) 2013-02-01 2017-03-21 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
CA2953881A1 (en) 2014-07-01 2016-01-07 Daiichi Sankyo Company, Limited Tricyclic benzoxaboroles as antibacterial agents
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
EP3426029B1 (en) 2016-03-07 2023-08-30 AgroFresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
WO2020232470A1 (en) 2019-05-13 2020-11-19 Boragen, Inc. Chemical compounds
BR112021026754A2 (pt) * 2019-07-03 2022-03-03 Borah Inc Composto, métodos para tratar um paciente com uma doença ou transtorno suscetível, para inibir janus quinase e para tratar uma ou mais doenças ou transtornos de inflamação, disfunção autoimune e câncer, composição, combinação, e, uso de um composto
WO2022043936A1 (en) 2020-08-31 2022-03-03 Pfizer Inc. Methods of protecting rna

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029A (en) * 1850-01-15 Winnowing-machike
US2260336A (en) 1939-10-16 1941-10-28 Dow Chemical Co Method of preparation of organic borates
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3686398A (en) 1970-07-20 1972-08-22 Chevron Res 10,9-boroxarophenanthrene as fungicides
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
GB1396904A (en) 1972-08-11 1975-06-11 Ici Ltd Method for the control of micro-organisms
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4602011A (en) 1975-10-24 1986-07-22 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4766113A (en) 1975-10-24 1988-08-23 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4716035A (en) 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US5962498A (en) 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5364791A (en) 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
DE69334150T2 (de) 1992-05-14 2008-03-13 Baylor College Of Medicine, Houston Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie
SG47101A1 (en) 1992-07-31 1998-03-20 Us Bioscience Crystalline amifostine compositions and methods for the preparation and use of same
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5348947A (en) 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5348948A (en) 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5594151A (en) 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
GB9500856D0 (en) 1995-01-17 1995-03-08 Zeneca Ltd Composition and use
GB9604926D0 (en) * 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
CA2258728C (en) 1996-06-19 2011-09-27 Rhone Poulenc Rorer Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
US5831046A (en) 1996-08-05 1998-11-03 Prolinx, Incorporated Boronic acid-contaning nucleic acid monomers
WO1998012206A1 (en) 1996-09-19 1998-03-26 The Board Of Trustees Of Leland Stanford Jr. University Dna adenine methyltransferases and uses thereof
EP0947498B1 (en) 1996-12-02 2004-09-15 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
US6221640B1 (en) 1997-05-14 2001-04-24 Cubist Pharmaceuticals, Inc. Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
DE19829947A1 (de) 1998-07-04 2000-01-05 Bayer Ag Elektrolumineszierende Anordnungen mit Bor-Chelaten
US6462036B1 (en) 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
CZ20011563A3 (cs) 1998-11-06 2003-02-12 Basf Aktiengesellschaft Tricyklické pyrazolové deriváty
WO2000044387A1 (fr) 1999-01-29 2000-08-03 Nitto Kasei Co., Ltd. Composes organobores presentant une activite de coccidiostats
CA2373279A1 (en) 1999-05-25 2000-12-14 The Penn State Research Foundation Dna methyltransferase inhibitors
US6306628B1 (en) 1999-08-25 2001-10-23 Ambergen, Incorporated Methods for the detection, analysis and isolation of Nascent proteins
DE60045879D1 (de) 1999-08-25 2011-06-01 Ambergen Inc Methoden zur Detektion, Analyse und Isolation von entstehenden Proteinen
AU7995300A (en) 1999-10-05 2001-05-10 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
AU784597B2 (en) 2000-01-06 2006-05-11 Marantech Holding, Llc Methods of using electron active compounds for managing cancer
US6521619B2 (en) 2000-06-29 2003-02-18 Icos Corporation Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
JP2004506417A (ja) 2000-07-14 2004-03-04 ザイコス インク. α−MSH関連化合物および使用方法
CA2430562C (en) 2000-11-30 2010-02-02 The Penn State Research Foundation Dna methyl transferase inhibitors
DE10110051C2 (de) 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de) 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
US7217701B2 (en) 2001-10-11 2007-05-15 Katsuhiko Mikoshiba Intracellular calcium concentration increase inhibitors
US7405304B2 (en) 2002-01-10 2008-07-29 The Penn State Research Foundation Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids
IL166156A0 (en) 2002-07-09 2006-01-15 Point Therapeutics Inc Boroproline compound combination therapy
ES2283867T3 (es) 2002-12-02 2007-11-01 Solvias Ag Hidrogenacion catalitica de dobles enlaces de carbonoheteroatomo.
JP2006511613A (ja) 2002-12-18 2006-04-06 アナコア ファーマシューティカルズ インコーポレイテッド ボロン酸複合体を含む抗生物質および使用法
US7390806B2 (en) 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
WO2005000200A2 (en) 2003-05-09 2005-01-06 Sugen, Inc. Novel kinases
RU2006101228A (ru) 2003-06-16 2006-07-27 Анакор Фармасьютикалз, Инк. (Us) Гидролитически устойчивые борсодержащие терапевтические агенты и способы их применения
ES2730728T3 (es) 2004-05-12 2019-11-12 Brigham & Womens Hospital Inc Uso de gelsolina para tratar infecciones
AR049915A1 (es) 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
WO2006062731A1 (en) 2004-11-19 2006-06-15 University Of North Texas Health Science Center At Fort Worth Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en) 2005-01-31 2005-03-09 Univ Cambridge Tech Compounds for use in chemical detection and/or quantitation
PL2987796T3 (pl) 2005-02-16 2018-12-31 Anacor Pharmaceuticals, Inc. Fluorowco-podstawione boronoftalidy do leczenia zakażeń
WO2006096131A1 (en) 2005-03-08 2006-09-14 Agency For Science, Technology And Research Chiral bisoxazoline catalysts
TW200722087A (en) 2005-03-30 2007-06-16 Astion Dev As Treatment of dermatological diseases and pruritus
US20080234229A1 (en) 2005-08-18 2008-09-25 Auspex Pharmaceuticals, Inc. Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
EP1976536A4 (en) 2005-12-30 2011-03-02 Anacor Pharmaceuticals Inc SMALL MOLECULES CONTAINING BORON
DK1988779T5 (en) 2006-02-16 2016-10-10 Anacor Pharmaceuticals Inc SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS
RU2008152367A (ru) 2006-06-12 2010-07-20 Анакор Фармасьютикалз, Инк. (Us) Соединения для лечения периодонтального заболевания
US20070286822A1 (en) 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
KR100895300B1 (ko) 2007-07-20 2009-05-07 한국전자통신연구원 생체신호 측정의복과 생체신호 처리시스템
WO2009111676A2 (en) 2008-03-06 2009-09-11 Anacor Pharmaceuticals, Inc Boron-containing small molecules as anti-inflammatory agents
MX2010009765A (es) 2008-03-06 2013-07-12 Anacor Pharmaceuticals Inc Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
WO2009140309A2 (en) 2008-05-12 2009-11-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010045505A1 (en) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Boron-containing small molecules as anti-protozoal agents
WO2010045503A1 (en) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents

Similar Documents

Publication Publication Date Title
JP2012502037A5 (ja)
JP2012255026A5 (ja)
JP2013542247A5 (ja)
JP2013518107A5 (ja)
JP2010504343A5 (ja)
JP2009545527A5 (ja)
JP2010536766A5 (ja)
JP2013014622A5 (ja)
JP2010077141A5 (ja)
JP2014515013A5 (ja)
JP2009502743A5 (ja)
JP2006526031A5 (ja)
JP2013525444A5 (ja)
JP2007302683A5 (ja)
JP2008513510A5 (ja)
JP2009537554A5 (ja)
JP2017537066A5 (ja)
JP2013507423A5 (ja)
JP2011527299A5 (ja)
JP2008533007A5 (ja)
JP2008513467A5 (ja)
JP2014507446A5 (ja)
JP2009507896A5 (ja)
JP2012072150A5 (ja)
JP2007302689A5 (ja)